Welcome

Celebrating Over 75 Years Of Service

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

ADVOCACY UPDATES

HHS Attestation Update

As AMA reported in the AMA Advocacy Update of May 22, HHS announced that providers need to…

read more

CARES Act and Public Health Emergency Funds Allocation

The Department of Health and Human Services (HHS) announced how it plans to allocate the…

read more

CARES Act Provider Relief Fund Additional Information

AMA Updates on CARES Act Today the Department of Health and Human Services (HHS) provided…

read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

04/15/20: Fellow Exam Application Deadline
Learn more

06/01/20: Research Grant Cycle
Learn more

06/26/20: Membership Application Deadline to be eligible for AAOA Member rate for the 2020 Basic Course Learn more

07/15/20: Call for Scientific Papers
Learn more

09/11/20: Membership Application Deadline to be voted in at the 2020 Annual Meeting and to be eligible for AAOA Member Rate (FREE) for the 2020 Annual Meeting Learn more

12/01/20: Research Grant Cycle
Learn more

EDUCATION

New Virtual Course!

Register now as we build out Part 2 Core Allergy & Part 3 Core Rhinology.   Both promise to deliver clinical content you need.  Core Allergy will offer what you need to help refresh or add allergy to your practice — everything from the clinical science to the basics of allergy from a better understanding of testing techniques, vial prep, and dose calculations to other practical implications.  Core Rhinology encompassed the highly sought after rhinology content from our former IAR program.  Part 1 will launch soon with on demand content to help you balance all your time demands.  Part 2 & 3 will feature live-stream content to give you opportunities to interact with the faculty.  Post live session, this content will also be available on demand. Stay tuned for more details as we finish our program build. Read More

IFAR

IFAR Impact Factor: 2.454

aaoaf-ifar

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Now Available

Changes in Managing Practices

Mission

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

NEW VIRTUAL COURSE! Core Allergy and Rhinology Concepts: Age of Pandemics and Beyond
Learn How to Reboot Your Practice and Freshen Up on Core Allergy and Rhinology Components
Learn More and Register

2020 Basic Course in Allergy & Immunology
July 9-11 | Orlando, FL
COVID-19 has made it impossible to convene our 2020 Basic Course. We hope you will consider another AAOA CME opportunity

2020 AAOA Annual Meeting
October 23-25| Scottsdale, AZ
Learn More and Register

2020 Advanced Course in Allergy & Immunology
December 9-12 | Vail, CO
Learn More and Register

AAOA Clinical Insights
Learn More and Register

USP 797 Online Module
Learn More and Register

2021 Basic Course in Allergy & Immunology
July 15-17 | Seattle, WA

News and Updates

Resuming SCIT During COVID-19 Pandemic

This summary is intended to provide practicing Otolaryngologists a guide to resuming safe allergy care…

read more

Small Business Paycheck Protection Program

by Dole Baker, MD, FAAOA, AAOA Socioeconomic Committee Member  Small Business Paycheck Protection Program is…

read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PATIENT CORNER

Menu

Health Policy Updates tied to COVID-19

HILL UPDATES

  • Senate Republicans released an updated version of the CARES Act on Sunday, March 22nd.  The amended package is estimated at $1.8 trillion, with the text available here. The funding provisions are included in Division B, which is available here. The updated summary from Senate Republicans is here.  
    • After two failed procedural votes on Sunday evening and Monday afternoon, negotiations continued through Monday on a bill that could gain the 60 votes needed to pass the procedural hurdle. Majority Leader McConnell said that a vote may not occur until Friday or Saturday.
  • On the other side of the Capitol, Speaker Pelosi released a separate version of the phase 3 stimulus package in the House earlier on Monday, the Take Responsibility for Workers and Families Act.  The bill provides additional appropriations funding for each of the 12 appropriations bills, including Labor, Health and Human Services appropriations.  The bill also includes provisions related to paid sick leave, protecting the health care workforce and related economic provisions.  We are providing summaries of a few key health care items below, and we will send a link to the updated bill text when we receive it.
    • Coverage of Testing and Treatment: the bill would extend coverage of COVID-19 testing and treatment for Medicaid, Medicare and private health insurance plans. It also provides optional coverage for uninsured individuals under Medicaid.
    • Other Health Care Provisions:
      • Extends funding for Community Health Centers, the National Health Service Corps, Teaching Centers that Operate GME Programs, the Special Diabetes Program and the Special Diabetes Program for Indians through November 30, 2020. This is a change from the Senate version that provided for a two-year extension.
      • Requires Part D plans to allow beneficiaries to obtain up to three-month supply of their Part D prescription drugs during the COVID-19 public health emergency. 
      • Clarifies coverage requirements for in vitro diagnostic tests in compliance with the Food and Drug Administration’s (FDA) guidance on diagnostic tests for COVID-19 during a public health emergency.
      • Includes a Sense of Congress that during the COVID-19 pandemic health care providers should refrain from balance billing consumers for out-of-network claims related to COVID-19 testing or treatment, and insurance companies should do their utmost to secure access to in-network treatment for their plan participants.
      • Allows for the National Disaster Medical System to reimburse for the cost of COVID-19 treatment expenses.
      • Provides additional support for public health data and surveillance systems, as well as the public health workforce.
      • Establishes a loan program to help eligible health care organizations with anticipated revenue loss or higher operating costs as a result of COVID-19. 
  • Today Senators Chris Murphy (D-CT) and Brian Schatz (D-HI) introduced the “Medical Supply Chain Emergency Act” that would force implementation of the Defense Production Act (DPA) of 1950. The bill would require the President to use authorities under the DPA to require emergency production of medical equipment to address the COVID-19 outbreak. Learn more here.  A House companion bill is expected to be introduced in the coming days.

ADMINISTRATION UPDATES

  • CMS released COVID-19 checklists and toolkits for state Medicaid and CHIP programs to help speed states’ access to emergency flexibilities and resources. A link to these resources can be found here: https://www.cms.gov/newsroom/press-releases/trump-administration-releases-covid-19-checklists-and-tools-accelerate-relief-state-medicaid-chip.
  • On March 22nd, CMS announced it is granting exceptions from reporting requirements and extensions for clinicians participating in Medicare quality reporting programs for upcoming measure reporting and data submission.  More details can be found here: https://www.cms.gov/newsroom/press-releases/cms-announces-relief-clinicians-providers-hospitals-and-facilities-participating-quality-reporting.
    • Provider Programs:
      • ESRD Quality Incentive Program: 2019 Q4 data submission is optional. CMS will not count data from January 1, 2020 through June 30, 2020.
      • Quality Payment Program and the Medicare Shared Savings Program: 2019 data submission deadline is extended by a month until April 30, 2020. Providers who don’t report by April 30 will qualify for the automatic extreme and uncontrollable circumstances policy and will receive a neutral payment adjustment for the 2021 MIPS payment year.  Options for the 2020 performance year are still being evaluated.
    • Hospital Programs:
      • ASC Quality Reporting Program: deadlines for October 1, 2019 to December 1, 2019 (Q4) data submission is optional. Data does not need to be submitted for January 1, 2020 to June 30, 2020.